Lewis JD - Search Results

1

The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

Lewis JD, Albenberg L, Lee D, Kratz M, Gottlieb K, Reinisch W. Lewis JD, et al. Inflamm Bowel Dis. 2017 Feb;23(2):181-191. doi: 10.1097/MIB.0000000000001009. Inflamm Bowel Dis. 2017. PMID: 28079619 Free PMC article. Review.

2

Cancer risk in patients with inflammatory bowel disease.

Lewis JD, Deren JJ, Lichtenstein GR. Lewis JD, et al. Gastroenterol Clin North Am. 1999 Jun;28(2):459-77, x. doi: 10.1016/s0889-8553(05)70065-0. Gastroenterol Clin North Am. 1999. PMID: 10372277 Free article. Review.

3

Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?

Su CG, Stein RB, Lewis JD, Lichtenstein GR. Su CG, et al. Among authors: lewis jd. Dig Liver Dis. 2000 Aug-Sep;32(6):518-31. doi: 10.1016/s1590-8658(00)80010-9. Dig Liver Dis. 2000. PMID: 11057928 Free article. Review.

4

Inflammatory bowel disease is not associated with an increased risk of lymphoma.

Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Lewis JD, et al. Gastroenterology. 2001 Nov;121(5):1080-7. doi: 10.1053/gast.2001.28703. Gastroenterology. 2001. PMID: 11677199

5

Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease.

Markowitz JE, Mamula P, delRosario JF, Baldassano RN, Lewis JD, Jawad AF, Culton K, Strom BL. Markowitz JE, et al. Among authors: lewis jd. Inflamm Bowel Dis. 2004 Sep;10(5):599-605. doi: 10.1097/00054725-200409000-00015. Inflamm Bowel Dis. 2004. PMID: 15472521

6

Design issues and outcomes in IBD clinical trials.

Sands BE, Abreu MT, Ferry GD, Griffiths AM, Hanauer SB, Isaacs KL, Lewis JD, Sandborn WJ, Steinhart AH. Sands BE, et al. Among authors: lewis jd. Inflamm Bowel Dis. 2005 Nov;11 Suppl 1:S22-8. doi: 10.1097/01.mib.0000184849.38816.39. Inflamm Bowel Dis. 2005. PMID: 16254479 Review.

7

Immunomodulators and the need for surgery in Crohn's disease: insufficient evidence to convict.

Lewis JD. Lewis JD. Inflamm Bowel Dis. 2005 Dec;11(12):1120-2. doi: 10.1097/01.mib.0000186493.50815.d9. Inflamm Bowel Dis. 2005. PMID: 16306776 No abstract available.

8

Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Osterman MT, et al. Among authors: lewis jd. Gastroenterology. 2006 Apr;130(4):1047-53. doi: 10.1053/j.gastro.2006.01.046. Gastroenterology. 2006. PMID: 16618398

9

Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.

Gupta G, Lautenbach E, Lewis JD. Gupta G, et al. Among authors: lewis jd. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1483-90. doi: 10.1016/j.cgh.2006.09.019. Clin Gastroenterol Hepatol. 2006. PMID: 17162240

10

Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease.

Morales A, Salguti S, Miao CL, Lewis JD. Morales A, et al. Among authors: lewis jd. Inflamm Bowel Dis. 2007 Apr;13(4):380-5. doi: 10.1002/ibd.20028. Inflamm Bowel Dis. 2007. PMID: 17206711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,176 results

Search Page